Home › Funds › Capital International Sarl › ONC

Capital International Sarl position in ONC

BEONE MEDICINES LTD · Health Care

Capital International Sarl reported holding 206,194 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$75.5M, representing 1.03% of its reported portfolio and ranking #27 among its reported holdings. Capital International Sarl has disclosed ONC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)206.19K sh
Reported value held$75.45M
Portfolio Weight1.03%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital International Sarl's ONC position evolved

Capital International Sarl first disclosed a stake in ONC in Q3 2023 at 165,545 shares (US$29.8M). The position peaked in Q3 2026 at 206,194 shares, worth US$75.5M. Across 13 filings, Capital International Sarl increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 206,194 shares valued at US$75.5M — an increase of 30,652 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 165.54K $29.78M New
Q4 2023 176.34K $31.80M Add
Q1 2024 191.94K $30.02M Add
Q2 2024 192.43K $27.45M Hold
Q3 2024 151.74K $34.07M Reduce
Q4 2024 152.71K $28.21M Add
Q1 2025 139.00K $37.83M Reduce
Q2 2025 133.92K $32.42M Reduce
Q3 2025 148.56K $50.61M Add
Q4 2025 152.51K $46.34M Add
Q1 2026 173.88K $51.64M Add
Q2 2026 175.54K $50.02M Add
Q3 2026 206.19K $75.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ONC and 13F data

ONC (BEONE MEDICINES LTD) is a Health Care company. 29 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ONC

All ONC fund holders →

FAQ

How long has Capital International Sarl held ONC?

Capital International Sarl has disclosed ONC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital International Sarl's current position in ONC?

As of Q3 2026, Capital International Sarl holds 206.19K shares of ONC (BEONE MEDICINES LTD), valued at $75.45M, representing 1.03% of its reported portfolio and ranking #27.

Has Capital International Sarl been buying or selling ONC?

In the latest 13F filing (Q3 2026), Capital International Sarl increased its position in ONC. The position peaked in Q3 2026 at 206.19K shares.

Which other funds hold ONC?

Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.